CD34 and breast carcinoma: We next planned to study the role of EndMT in angiogenesis of breast cancer, then we performed double-IHC staining for EndMT markers (α-SMA, FSP-1, Vimentin, VE-Cadherin and Fibronectin), and MVD (CD34, vWF) on IDC samples.